DIA 2013 49th Annual Meeting
Click here to go to the previous page
Advancing Alzheimer's Innovation: Patient Advocacy, Caregiver Support and Health Care System Impact
Track : Track 08:Regulatory Affairs and Submissions
Program Code: 348
Date: Wednesday, June 26, 2013
Time: 1:45 PM to 3:15 PM  EST
Location: 253A
CHAIR :
 Robert Feeney, MBA (SCHNON), Senior Director, Evidence-Based Reimbursement, Sanofi, United States
SPEAKER (S):
Cynthia Bens, (SPKSUP), VP, Public Policy, Accelerate Cure/Treatments for Alzheimer's Disease (ACT-AD), Alliance for Aging Research, United States
 Francesca Cerreta, PharmD,MPharm,MS (SCHAGY), Scientific Administrator, European Medicines Agency, European Union, United Kingdom
Drew Holzapfel, MBA (SPKNON), Executive Director, The Global CEO Initiative On Alzheimer's Disease, United States
Description
As researchers work towards disease modifying therapies, we must also press ahead on initiatives that prepare society for the proper care of Alzheimer's sufferers — and caregivers. A small number of nations — France, the United Kingdom and Australia among them — have created comprehensive national policies to manage Alzheimer's disease and to offer compassionate care to its sufferers. Employers are also being impacted by loss of productivity and responding by increasing their support for employees who are providing care to loved ones with Alzheimer's and other age-related chronic conditions. Private sector innovation is also starting to respond to the growing need to help individuals remain independent for as long as possible. This forum will focus on best practices in care delivery to support patients and caregivers, whether in institutions or at home.